Texas 2025 - 89th Regular

Texas Senate Bill SB122 Latest Draft

Bill / Introduced Version Filed 11/12/2024

Download
.pdf .doc .html
                            89R2547 KKR-D
 By: Hall S.B. No. 122




 A BILL TO BE ENTITLED
 AN ACT
 relating to required labeling of certain products containing or
 derived from aborted human fetal tissue.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subchapter D, Chapter 431, Health and Safety
 Code, is amended by adding Section 431.085 to read as follows:
 Sec. 431.085.  LABELING REQUIRED FOR FETAL TISSUE FOOD
 PRODUCT. (a) In this section:
 (1)  "Fetal tissue food product" means a food or food
 additive that:
 (A)  contains human fetal tissue;
 (B)  is manufactured using human fetal tissue; or
 (C)  is otherwise derived from research using
 human fetal tissue.
 (2)  "Human fetal tissue" means tissue, cells,
 including cells from fetal cell lines, or organs obtained or
 originally derived from an aborted unborn child.
 (b)  A person may not sell in this state a fetal tissue food
 product unless the product is clearly and conspicuously labeled in
 accordance with department rules.
 (c)  The executive commissioner by rule shall prescribe the
 form and contents of the label required by Subsection (b).
 SECTION 2.  Subchapter E, Chapter 431, Health and Safety
 Code, is amended by adding Section 431.118 to read as follows:
 Sec. 431.118.  LABELING REQUIRED FOR FETAL TISSUE MEDICAL
 PRODUCT. (a) In this section:
 (1)  "Fetal tissue medical product" means a medication,
 vaccine, or other medical product used in medical treatment that:
 (A)  contains human fetal tissue;
 (B)  is manufactured using human fetal tissue; or
 (C)  is otherwise derived from research using
 human fetal tissue.
 (2)  "Human fetal tissue" means tissue, cells,
 including cells from fetal cell lines, or organs obtained or
 originally derived from an aborted unborn child.
 (b)  A person may not sell, dispense, or administer in this
 state a fetal tissue medical product unless the product is clearly
 and conspicuously labeled in accordance with department rules.
 (c)  The executive commissioner by rule shall prescribe the
 form and contents of the label required by Subsection (b).
 SECTION 3.  Subchapter F, Chapter 431, Health and Safety
 Code, is amended by adding Section 431.143 to read as follows:
 Sec. 431.143.  LABELING REQUIRED FOR FETAL TISSUE COSMETIC
 PRODUCT. (a) In this section:
 (1)  "Fetal tissue cosmetic product" means a cosmetic
 product that:
 (A)  contains human fetal tissue;
 (B)  is manufactured using human fetal tissue; or
 (C)  is otherwise derived from research using
 human fetal tissue.
 (2)  "Human fetal tissue" means tissue, cells,
 including cells from fetal cell lines, or organs obtained or
 originally derived from an aborted unborn child.
 (b)  A person may not sell in this state a fetal tissue
 cosmetic product unless the product is clearly and conspicuously
 labeled in accordance with department rules.
 (c)  The executive commissioner by rule shall prescribe the
 form and contents of the label required by Subsection (b).
 SECTION 4.  (a) Not later than December 1, 2025, the
 executive commissioner of the Health and Human Services Commission
 shall adopt the form and content of the labels required under
 Sections 431.085, 431.118, and 431.143, Health and Safety Code, as
 added by this Act.
 (b)  Sections 431.085, 431.118, and 431.143, Health and
 Safety Code, as added by this Act, apply only to a fetal tissue
 product sold, dispensed, or administered on or after January 1,
 2026.
 SECTION 5.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2025.